Mechanisms of Fibrogenesis

Fibrogenesis is a mechanism of wound healing and repair. However, prolonged injury causes deregulation of normal processes and results in extensive deposition of extracellular matrix (ECM) proteins and fibrosis. The current review will discuss similarities and differences of fibrogenesis in different organs and systems and focus on the origin of collagen producing cells. Although the relative contribution will vary in different tissues and different injuries, there are three general sources of fibrogenic cells: endogenous fibroblasts or fibroblast-like cells, epithelial to mesenchymal transition, and recruitment of fibrocytes from the bone marrow.

[1]  A. Desmoulière,et al.  The Myofibroblast: one function, multiple origins , 2010 .

[2]  Vinay Kumar,et al.  Tissue Renewal and Repair: Regeneration, Healing, and Fibrosis , 2010 .

[3]  R. Mahfouz,et al.  Understanding the biology of angiogenesis: review of the most important molecular mechanisms. , 2007, Blood cells, molecules & diseases.

[4]  S. Kaneko,et al.  Fibrocytes: a new insight into kidney fibrosis. , 2007, Kidney international.

[5]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[6]  Kurt R Stenmark,et al.  Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[7]  Benjamin D. Sachs,et al.  p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway , 2007, The Journal of cell biology.

[8]  S. Akira,et al.  Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.

[9]  F. Verrecchia,et al.  Transforming growth factor-β and fibrosis , 2007 .

[10]  M. Ushio-Fukai.  VEGF signaling through NADPH oxidase-derived ROS. , 2007, Antioxidants & redox signaling.

[11]  Marta Ruiz-Ortega,et al.  TGF-β signaling in vascular fibrosis , 2007 .

[12]  Paul Martin,et al.  The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. , 2007, The Journal of investigative dermatology.

[13]  J. Fallowfield,et al.  Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis1 , 2007, The Journal of Immunology.

[14]  D. Brenner,et al.  The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. , 2007, Gastroenterology.

[15]  David C. Jones,et al.  Biliary epithelial‐mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis , 2007, Hepatology.

[16]  Zhiwei Yang,et al.  Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice , 2007, The Journal of cell biology.

[17]  J. Iredale.  Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. , 2007, The Journal of clinical investigation.

[18]  B. Hinz.  Formation and function of the myofibroblast during tissue repair. , 2007, The Journal of investigative dermatology.

[19]  R. Strieter,et al.  The role of CXC chemokines in pulmonary fibrosis. , 2007, The Journal of clinical investigation.

[20]  H. Nakano,et al.  Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway. , 2007, Molecular biology of the cell.

[21]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[22]  Andrew J Link,et al.  A proximal activator of transcription in epithelial-mesenchymal transition. , 2007, The Journal of clinical investigation.

[23]  J. Roes,et al.  Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. , 2007, The American journal of pathology.

[24]  Marta Ruiz-Ortega,et al.  TGF-beta signaling in vascular fibrosis. , 2007, Cardiovascular research.

[25]  S. Kaufmann,et al.  Ito cells are liver-resident antigen-presenting cells for activating T cell responses. , 2007, Immunity.

[26]  N. Kojima,et al.  Vitamin A-storing cells (stellate cells). , 2007, Vitamins and hormones.

[27]  F. Verrecchia,et al.  Transforming growth factor-beta and fibrosis. , 2007, World journal of gastroenterology.

[28]  Q. Ao,et al.  Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle‐like cells regulated by myocardin involved in hypoxia‐induced pulmonary vascular remodelling , 2006, International journal of experimental pathology.

[29]  R. Murphy,et al.  Immunomodulatory role of vascular endothelial growth factor and angiopoietin-1 in airway remodeling. , 2006, Current molecular medicine.

[30]  Ronald C. Petersen,et al.  Conversion , 2006, Neurology.

[31]  R. Bucala,et al.  Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy) , 2006, Current opinion in rheumatology.

[32]  J. Sicklick,et al.  Evidence for epithelial-mesenchymal transitions in adult liver cells. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[33]  C. Wilcox,et al.  NADPH oxidases in the kidney. , 2006, Antioxidants & redox signaling.

[34]  S. Kaneko,et al.  Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis , 2006, Proceedings of the National Academy of Sciences.

[35]  R. Schwabe,et al.  Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. , 2006, Journal of hepatology.

[36]  T. Krieg,et al.  Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. , 2006, The journal of investigative dermatology. Symposium proceedings.

[37]  D. Brenner,et al.  Hepatic stellate cells and the reversal of fibrosis , 2006, Journal of gastroenterology and hepatology.

[38]  D. Brenner,et al.  Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis , 2006, Hepatology.

[39]  J. Varga,et al.  Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers , 2006, Expert opinion on pharmacotherapy.

[40]  Y. Liu,et al.  Hepatocyte growth factor: new arsenal in the fights against renal fibrosis? , 2006, Kidney international.

[41]  D. Sheppard,et al.  Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. , 2006, Proceedings of the American Thoracic Society.

[42]  S. Phan,et al.  The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. , 2006, Proceedings of the American Thoracic Society.

[43]  J. Horowitz,et al.  Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. , 2006, Proceedings of the American Thoracic Society.

[44]  B. Willis,et al.  Epithelial origin of myofibroblasts during fibrosis in the lung. , 2006, Proceedings of the American Thoracic Society.

[45]  Youhua Liu,et al.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. , 2006, The American journal of pathology.

[46]  S. Forbes,et al.  The bone marrow functionally contributes to liver fibrosis. , 2006, Gastroenterology.

[47]  R. Bucala,et al.  The role of circulating fibrocytes in fibrosis , 2006, Current rheumatology reports.

[48]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[49]  V. Steen.  Targeted therapy for systemic sclerosis. , 2006, Autoimmunity reviews.

[50]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[51]  S. Friedman,et al.  Reversal of hepatic fibrosis — Fact or fantasy? , 2006, Hepatology.

[52]  E. Neilson,et al.  Toward a unified theory of renal progression. , 2006, Annual review of medicine.

[53]  T. Sugiyama,et al.  Fas‐associated phosphatase‐1 promotes Fas‐mediated apoptosis in human colon cancer cells: Novel function of FAP‐1 , 2006, Journal of gastroenterology and hepatology.

[54]  S. Lepreux,et al.  Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. , 2005, The international journal of biochemistry & cell biology.

[55]  S. Dooley,et al.  TGF-β/Smad Signaling in the Injured Liver , 2006 .

[56]  W. Qi,et al.  The renal cortical fibroblast in renal tubulointerstitial fibrosis. , 2006, The international journal of biochemistry & cell biology.

[57]  G. Thomas,et al.  Alphavbeta6 integrin in wound healing and cancer of the oral cavity. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[58]  J. Egido,et al.  Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[59]  M. Burdick,et al.  The FASEB Journal express article 10.1096/fj.05-4295fje. Published online September 27, 2005. , 2022 .

[60]  G. Prestwich,et al.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.

[61]  S. Akira,et al.  Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. , 2005, The Journal of clinical investigation.

[62]  E. Tremoli,et al.  Anti-inflammatory properties of drugs acting on the renin-angiotensin system. , 2005, Drugs of today.

[63]  K. Csiszȧr,et al.  Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis , 2005, Arthritis research & therapy.

[64]  D. Tarin,et al.  The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.

[65]  Junitsu Ito,et al.  NAD(P)H oxidase plays a crucial role in PDGF‐induced proliferation of hepatic stellate cells , 2005, Hepatology.

[66]  J. Horowitz,et al.  Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[68]  R. Wells.  The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. , 2005, Journal of clinical gastroenterology.

[69]  T. Moore,et al.  CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. , 2005, The American journal of pathology.

[70]  Joe G. N. Garcia,et al.  In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. , 2005, Cellular signalling.

[71]  S. Nénan,et al.  The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis , 2005, Respiratory research.

[72]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[73]  Giulio Gabbiani,et al.  Perspective Article: Tissue repair, contraction, and the myofibroblast , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[74]  Junwei Yang,et al.  A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. , 2004, Journal of the American Society of Nephrology : JASN.

[75]  R. Bataller,et al.  Amendment history : Corrigendum ( April 2005 ) Liver fibrosis Ramón Bataller , 2018 .

[76]  D. Brenner,et al.  Fibrosis research : methods and protocols , 2005 .

[77]  J. Zavadil,et al.  TGF-beta and epithelial-to-mesenchymal transitions. , 2005, Oncogene.

[78]  G. Lang,et al.  Effect of extracellular matrix on proliferation and differentiation of porcine lens epithelial cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[79]  J. Oppenheim,et al.  Antimicrobial proteins act as "alarmins" in joint immune defense. , 2004, Arthritis and rheumatism.

[80]  M. Burdick,et al.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. , 2004, The Journal of clinical investigation.

[81]  J. Bonner,et al.  Regulation of PDGF and its receptors in fibrotic diseases. , 2004, Cytokine & growth factor reviews.

[82]  K. Kuwano,et al.  The role of apoptosis in pulmonary fibrosis. , 2004, Histology and histopathology.

[83]  D. Rifkin,et al.  Integrin αVβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1 , 2004, The Journal of cell biology.

[84]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[85]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  S. Phan,et al.  Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.

[87]  B. Perbal.  CCN proteins: multifunctional signalling regulators , 2004, The Lancet.

[88]  CanLI,et al.  Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal , 2004 .

[89]  C. Hill,et al.  New insights into TGF-beta-Smad signalling. , 2004, Trends in biochemical sciences.

[90]  R. Kalluri,et al.  The role of epithelial-to-mesenchymal transition in renal fibrosis , 2004, Journal of Molecular Medicine.

[91]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[92]  A. Desmoulière,et al.  Normal and Pathologic Soft Tissue Remodeling: Role of the Myofibroblast, with Special Emphasis on Liver and Kidney Fibrosis , 2003, Laboratory Investigation.

[93]  A. Roberts,et al.  Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. , 2003, The Journal of clinical investigation.

[94]  R. Gomer,et al.  Inhibition of Fibrocyte Differentiation by Serum Amyloid P 1 , 2003, The Journal of Immunology.

[95]  R. Schwabe,et al.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. , 2003, The Journal of clinical investigation.

[96]  J. Iredale,et al.  Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[97]  Gábor Sirokmány,et al.  Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition , 2003 .

[98]  Arthur S Slutsky,et al.  Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. , 2003, JAMA.

[99]  A. Anjo,et al.  Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition. , 2003, Blood.

[100]  J. Greenberger,et al.  Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.

[101]  J. Estrela,et al.  In vivo antioxidant treatment protects against bleomycin‐induced lung damage in rats , 2003, British journal of pharmacology.

[102]  R. Hultcrantz,et al.  The Myofibroblastic Conversion of Peribiliary Fibrogenic Cells Distinct from Hepatic Stellate Cells Is Stimulated by Platelet-Derived Growth Factor During Liver Fibrogenesis , 2003, Laboratory Investigation.

[103]  Richard J. Johnson,et al.  Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis , 2003, Current opinion in nephrology and hypertension.

[104]  R. Gamelli,et al.  Mast cells modulate the inflammatory but not the proliferative response in healing wounds , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[105]  J. Calleja,et al.  Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement , 2003, Hepatology.

[106]  Gábor Sirokmány,et al.  Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. , 2003, American journal of physiology. Renal physiology.

[107]  S. Phan.  The myofibroblast in pulmonary fibrosis. , 2002, Chest.

[108]  Marcia Simon,et al.  Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFβ1 , 2002, BMC dermatology.

[109]  R. Oostendorp,et al.  Comparative study of stromal cell lines derived from embryonic, fetal, and postnatal mouse blood-forming tissues. , 2002, Experimental hematology.

[110]  G. Schmid-Schönbein,et al.  The Inflammatory Aspect of the Microcirculation in Hypertension: Oxidative Stress, Leukocytes/Endothelial Interaction, Apoptosis , 2002, Microcirculation.

[111]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[112]  D. Herzlinger.  Renal interstitial fibrosis: remembrance of things past? , 2002, The Journal of clinical investigation.

[113]  Mark Peifer,et al.  The Ballet of Morphogenesis Unveiling the Hidden Choreographers , 2002, Cell.

[114]  D. Warburton,et al.  Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[115]  D. Brenner,et al.  Akt protects mouse hepatocytes from TNF-α- and Fas-mediated apoptosis through NK-κB activation , 2001 .

[116]  D. Schuppan,et al.  Matrix as a modulator of hepatic fibrogenesis. , 2001, Seminars in liver disease.

[117]  J. Iredale.  Hepatic Stellate Cell Behavior during Resolution of Liver Injury , 2001, Seminars in liver disease.

[118]  D. Brenner,et al.  The role of Smad3 in mediating mouse hepatic stellate cell activation , 2001, Hepatology.

[119]  J. Zavadil,et al.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[120]  F. Strutz,et al.  Renal fibrosis: an update , 2001, Current opinion in nephrology and hypertension.

[121]  V. Carloni,et al.  The alpha6 beta1 integrin is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of hepatocarcinoma cells , 2001 .

[122]  S. Dooley,et al.  Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts , 2001 .

[123]  H. van Goor,et al.  Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. , 2001, Liver.

[124]  D. Brenner,et al.  Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[125]  S. Dooley,et al.  Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. , 2001, FEBS letters.

[126]  F. Strutz,et al.  Role of fibroblast activation in inducing interstitial fibrosis. , 2000, Journal of nephrology.

[127]  B. Boyer,et al.  Induction and regulation of epithelial-mesenchymal transitions. , 2000, Biochemical pharmacology.

[128]  S. Segerer,et al.  Metanephrogenic mesenchyme-to-epithelium transition induces profound expression changes of ion channels. , 2000, American journal of physiology. Renal physiology.

[129]  J. Murphy-Ullrich,et al.  Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology , 2000 .

[130]  W. Piotrowski,et al.  Cellular sources of oxidants in the lung. , 2000, International journal of occupational medicine and environmental health.

[131]  J. Murphy-Ullrich,et al.  Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. , 2000, Cytokine & growth factor reviews.

[132]  A. Ichihara,et al.  BCA, HGF, and proteasomes. , 1999, Biochemical and biophysical research communications.

[133]  F. Piscaglia,et al.  Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. , 1999, Gastroenterology.

[134]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[135]  S. Nagata,et al.  Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. , 1999, The Journal of clinical investigation.

[136]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[137]  Y. Kaneda,et al.  Hepatocyte growth factor gene therapy of liver cirrhosis in rats , 1999, Nature Medicine.

[138]  C. Niehrs,et al.  Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. , 1999, Nature.

[139]  M. Alison.  Liver stem cells: a two compartment system. , 1998, Current opinion in cell biology.

[140]  G. Remuzzi,et al.  Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.

[141]  H. Lodish,et al.  Oligomeric Structure of Type I and Type II Transforming Growth Factor β Receptors: Homodimers Form in the ER and Persist at the Plasma Membrane , 1998, The Journal of cell biology.

[142]  R. Kalluri,et al.  Early role of Fsp1 in epithelial-mesenchymal transformation. , 1997, American journal of physiology. Renal physiology.

[143]  K. Kuwano,et al.  Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. , 1997, American journal of respiratory cell and molecular biology.

[144]  L. D. Nielsen,et al.  Surfactant protein and CC-10 expression in acute lung injury and in response to keratinocyte growth factor. , 1997, Chest.

[145]  D. Speicher,et al.  KAP-1, a novel corepressor for the highly conserved KRAB repression domain. , 1996, Genes & development.

[146]  L. Rubbia‐Brandt,et al.  Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[147]  R. Bucala,et al.  Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.

[148]  I. Ichikawa,et al.  Renal antioxidant enzymes: their regulation and function. , 1994, Kidney international.

[149]  J. Maher,et al.  Cell-matrix interactions in liver. , 1993, Seminars in cell biology.

[150]  H. Schwarz,et al.  Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion , 1992, Cell.

[151]  S. Kamada,et al.  A protein binding to CArG box motifs and to single-stranded DNA functions as a transcriptional repressor. , 1992, Gene.

[152]  H. Starklint,et al.  Long-term cyclosporin nephrotoxicity in the rat: effects on renal function and morphology. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[153]  C. Takiya,et al.  Connective matrix organization in human pulmonary fibrosis , 1983, Virchows Archiv. B, Cell pathology including molecular pathology.